There was no clear reason for this heterogeneity. Trials of preventative PFMT started pre or post-operatively also showed heterogeneity: only one large trial favoured PFMT but the data from the others were conflicting.
Analysis of other conservative interventions such as transcutaneous electrical nerve stimulation and anal electrical stimulation, or combinations of these interventions were inconclusive. There were too few data to determine treatment effects on incontinence after TURP. The findings should continue to be treated with caution, as most studies were of poor to moderate quality.
With respect to other management, men in one trial reported a preference for one type of external compression device compared to two others or no treatment. The effect of other conservative interventions such as lifestyle changes remains undetermined as no trials involving these interventions were identified. Men's symptoms tended to improve over time, irrespective of management.
Authors' conclusions
The value of the various approaches to conservative management of postprostatectomy incontinence remains uncertain. Long-term incontinence may be managed by external penile clamp, but there are safety problems.
P L A I N L A N G U A G E S U M M A R Y
Overall effectiveness of conservative management of postprostatectomy urinary incontinence remains unclear.
The prostate is a male sex gland that surrounds the outlet of the bladder. Two main diseases of the prostate (cancer of the prostate, or benign prostatic enlargement) can be treated by surgery but some men suffer leakage of urine (urinary incontinence) afterwards. Conservative treatment of the leakage, such as pelvic floor muscle training with or without biofeedback or anal electrical stimulation are thought to help men control this leakage. The review of trials found that there was conflicting information about the benefit of pelvic floor muscle training for either prevention or treatment of urine leakage after prostate surgery, whether for cancer or benign (non cancerous) enlargement of the prostate (endoscopic resection). Of three external compression devices tested, one type seemed to be better than the others but needs to be used cautiously because of safety risks. More research of better quality is needed to assess conservative managements.
B A C K G R O U N D
It is not uncommon for men to have urinary incontinence (UI) after prostatectomy. The reported frequency varies depending on the type of surgery and surgical technique (Grise 2001; Peyromaure 2002) , the definition and quantification of incontinence (Grise 2001; Peyromaure 2002) , the timing of the evaluation relative to the surgery, and who evaluates the presence or absence of incontinence (physician or patient) (Donnellan 1997; McCammon 1999) . Reported prevalence rates of UI after radical prostatectomy (RP) for prostate cancer vary from 5% to over 60% (Hunskaar 2002) . For example, in one study at three months after RP (Donnellan 1997), 51% were subjectively wet (self-report) but 36% were wet on pad testing (objective). By 12 months, 20% were subjectively still wet, but only 16% were classed as wet using objective criteria. After transurethral resection of the prostate (TURP) for benign prostate disease, UI is less common at three months after operation (e.g. 10% needing to wear pads), but longer term data are not available (Emberton 1996) .
After both types of operation, the problem tends to improve with time: it declines and plateaus within one to two years postoperatively (Hunskaar 2002) . However, some men are left with incontinence that persists for years afterwards.
Continence mechanisms
Urinary continence depends on a complex interaction of smooth and striated muscle fibres blended together to form the continence mechanism. Considerable debate has existed in the literature as to whether incontinence after prostatectomy is due to an effect on the detrusor (bladder) muscle or on the sphincter, as commonly these abnormalities coexist (Peyromaure 2002) . New detrusor overactivity and intrinsic sphincter deficiency due to sphincteric injury (Ficazzola 1998; Groutz 2000; McGuire 1990) or weakness (Majoros 2006) are cited as the most important causes of persistent incontinence after RP. Debate continues on whether detrusor overactivity is a primary or secondary factor. Whereas some report overactivity as the primary cause of postprostatectomy incontinence (Golubuff 1995; Leach 1995) others argue strongly that even if other factors play a role, intrinsic sphincter deficiency is the primary cause of UI after RP (Aboseif 1996; Chao 1995; Groutz 2000; Gudziak 1996; Kondo 2002; Majoros 2006; Winters 1997) .
Risk factors for postprostatectomy UI after RP include pre-existing abnormalities of detrusor contractility (Leach 1995) and older age (Diokno 1997; Kondo 2002) (possibly due to progressive reduction in sphincter striated muscle cells with age, (Strasser 1997) ).
Other risk factors include previous TURP (Jacobsen 2007); preoperative radiotherapy (Kondo 2002; Rainwater 1988) ; trauma; spinal cord lesion; new obstruction due to recurrence, bladder neck contracture, or urethral stricture (Litwiller 1997); Parkinson's disease (Kondo 2002); dementia; and medications (Khan 1991) . A surgeon's inadequate skill and expertise (Eastham 1996) and having surgery in a hospital which performs fewer than 20 radical prostatectomies a year may also be a factor (Albertsen 1997).
After TURP, UI is thought to most likely be due to pre-existing abnormalities of bladder function such as poor compliance or detrusor overactivity, rather than direct sphincter injury (Abrams 1991), possibly because removal of the prostatic tissue removed some of the protective mechanism for continence.
The treatments recommended for postprostatectomy UI are usually 'conservative,' not involving drugs or surgery. Six categories of conservative management are considered in this review, singly and in combination when appropriate.
Pelvic floor muscle training (PFMT)
This involves any method of training the pelvic floor muscles to contract, including teaching performance of an accurate voluntary pelvic floor muscle contraction using biofeedback, and coordinating and timing the contraction against increases in intra-abdominal pressure, often called functional PFMT.
Traditionally, biofeedback involves the use of equipment to provide visual or auditory feedback about the pelvic floor muscle function to enable one to train, strengthen and increase endurance and coordination of the pelvic floor muscle contractions. Simple auditory biofeedback can also be provided by the therapist informing the patient when a contraction is felt through digital anal examination during the pelvic floor muscle contraction.
The theoretical basis of PFMT is that repeated, volitional contractions of selected pelvic floor muscles may improve their strength and efficiency during periods of increased intra-abdominal pressure. In a systematic review of the literature on female UI, Berghmans and colleagues noted that a pelvic floor muscle contraction may raise the urethra and press it towards the symphysis pubis, prevent urethral descent, and improve structural support of the pelvic organs (Berghmans 1998). They further pointed out that PFMT may result in hypertrophy of the periurethral striated muscles thereby increasing the 'external mechanical pressure on the urethra'.
Electrical stimulation (non-invasive) delivered via surface electrodes.
• Anal electrical stimulation Any type of electrical stimulation using a non-invasive surface anal probe designed for the therapy. The intention of electrical stimulation is to facilitate contraction of the periurethral striated muscle.
• Sticky patch electrodes, also called transcutaneous electrical nerve stimulation (TENS).
Transcutaneous electrical nerve stimulation is a low intensity, sensory nerve stimulation used for detrusor overactivity, delivered at various sites, using patch electrodes. Sites include the sacral dermatomes (Hasan 1996) , dorsal penile nerve (Nakamura 1984), hamstring and quadriceps muscle (Okada 1998) , and the posterior tibial or perineal nerves (McGuire 1983) .
Lifestyle adjustment
This includes fluid adjustment, diet, caffeine elimination, physical exercise, weight loss and cessation of smoking.
Extra-corporeal magnetic innervation
This involves the use of a magnetic chair to stimulate contraction of the pelvic floor muscles (Galloway 2000).
External penile compression devices
These devices use an external clamp to achieve non-surgical compression of the urethra.
The initial review on the topic of postprostatectomy UI, first published in 1999 (Moore 1999b ) and updated in 2001 (Moore 2001 , only considered post operative PFMT, biofeedback and electrical stimulation. In the last update (Hunter 2004) , the review was broadened to include studies evaluating lifestyle adjustment, external penile compression devices and extracorporeal magnetic innervation. The current update includes studies on men after TURP.
O B J E C T I V E S
To determine the effects of conservative management for UI after transurethral, suprapubic, laparoscopic, radical retropubic or perineal prostatectomy, including any single conservative therapy or any combination of conservative therapies. Pharmacological agents will be considered in separate reviews. The use of the term 'sham therapy' in this review means any therapy that could not influence the pelvic floor muscles such as placing an electrical stimulation probe in the anus but not turning it on.
The following comparisons were made for treatment and/or prevention of UI after prostatectomy:
Radical prostatectomy Treatment (of incontinent men, after surgery) (1) post-operative PFMT with or without biofeedback versus no treatment or sham therapy or verbal instruction; (2) post-operative interventions using electric or magnetic energy (e.g. post-operative anal electrical stimulation, perineal electrical stimulation, transcutaneous electrical nerve stimulation (TENS), extracorporeal magnetic innervation (ExMI)) versus no treatment or sham treatment; We have not listed all possible comparisons here. As and when new trials address new comparisons these will be added to the review.
C R I T E R I A F O R C O N S I D E R I N G S T U D I E S F O R T H I S R E V I E W

Types of studies
Randomised or quasi-randomised controlled trials of conservative management to prevent or treat UI after TURP or RP were sought.
Types of participants
Men undergoing a prostatectomy for either benign prostatic hyperplasia or prostate cancer. Studies involving men experiencing UI prior to prostatectomy were excluded.
Types of intervention
PFMT; biofeedback (verbal or machine-mediated); electrical stimulation via a surface electrode (e.g. anal probe electrical stimulation; sticky patch electrode; transcutaneous electrical nerve stimulation (TENS)); extra-corporeal magnetic innervation (ExMI); lifestyle adjustment; and external penile compression devices. These interventions can be compared with no treatment or with each other, alone or in combination. 
Types of outcome measures
Other outcomes
Non pre-specified outcomes judged important when performing the review.
S E A R C H M E T H O D S F O R I D E N T I F I C A T I O N O F S T U D I E S
See: Cochrane Incontinence Group methods used in reviews. Extra specific searches were also performed. These are detailed below.
Systematic searches of electronic bibliographic databases
The following electronic bibliographic databases were searched (date search was performed: 10 January 
Handsearching of conference proceedings
The following conference proceedings were handsearched:
• American Urological Association (years searched: 1989-2005) Supplement to the Journal of Urology, published as a supplement.
• Society of Urologic Nurses and Associates (SUNA) (formerly American Urologic Association Allied) these abstracts are not published but are available in the SUNA office. Annual meeting (years searched: 1991 to 2003 1991-Las Vegas, NV; 1992-Washington, DC; 1993-San Antonio, TX; 1994-San Francisco, CA; 1995-Las Vegas,NV; 1996 -Orlando, FL, 1997 -New Orleans, LA. Biannual incontinence meeting: 1992 -Tampa, Fla (1st meeting), 1994 -Phoenix, 1996 -Dallas, 1998 -Orlando, 2000 -Nashville, 2004 -Chicago, 2006 Understanding urodynamics seminar:1993-Denver, CO; 1994-San Antonio, TX; 1995-Cleveland, OH; 1996-St Louis, MO.
• Wound Ostomy and Continence Nurses (years searched: 1996, 1997,1999 to 2006 
Reference lists of relevant articles
The reference lists of relevant articles were searched for other possibly relevant trials.
Contact with investigators in the field
Investigators were contacted to ask for other possibly relevant trials, published or unpublished.
No language or other limits were imposed on the searches.
M E T H O D S O F T H E R E V I E W
The methodological quality of the trials was assessed using the Cochrane Incontinence Group's criteria presented in the The Cochrane Library. The Group's assessment tool is not scored. The following methodological parameters are included: 1) identification of study as randomised or quasi-randomised; 2) description of inclusion/exclusion criteria; 3) potential for selection bias (quality of random allocation concealment) rating; 1999 -2001) . Disagreements were resolved through discussion; third party arbitration was not required.
Data for the trials added to the 2004 and 2006 updates were extracted independently by two reviewers (KFH and KNM) using a standard form developed for this purpose. The following information was included:
• study method and characteristics (design, method of randomisation, inclusion/exclusion criteria, withdrawals/dropouts);
• participants (population, age);
• type of intervention, timing and duration of therapy, cointerventions;
• control (no treatment or sham therapy or other active treatment);
• outcomes (types of outcome measures, reported outcomes, adverse events).
Extracted data were compared by two review authors (KFH and KNM) for completeness and accuracy, and cross checked by another review author (CG). Disagreements were resolved through discussion and review of the trial report. Data were entered into Review Manager software (RevMan 4.2.3) by KFH and KNM. The data were evaluated for publication bias using graphical (i.e. funnel plot) evaluation only. This is presented in the results section.
For dichotomous outcomes, data were summarized (e.g. number of people for whom an outcome is present or not) and relative risks (RR) calculated with their 95% CIs. For continuous outcomes, each trial was summarised using the mean value for each group and SDs, and combined as weighted mean differences (WMD) if the same scale (e.g. pad test in grams of urine) was used for the outcome measurement in more than one trial. A fixed effect model was used to calculate the summary statistic and the 95% confidence intervals. Heterogeneity was assessed visually and using the Chi-squared test for heterogeneity and the I-squared statistic (Higgins 2003) . Forest plots were examined and potential sources influencing heterogeneity identified. Possible sources of heterogeneity were explored statistically through subgroup analysis. Where synthesis was deemed not appropriate, a narrative overview was planned.
Comparisons of the outcomes of the chosen interventions with no treatment, with each other, and in combination were planned a priori for the review update. Data were not available for all planned comparisons. In planning the update, subgroup analysis based on type of surgery (RP or TURP) was planned. As there was considerable diversity in the length of time interventions were carried out and in how this time was reported, the data were further divided into categories by length of time.
Attempts were made to contact authors of trial reports if clarification was necessary. Included trial data were processed as described in the Cochrane Collaboration Handbook (Higgins 2005). Studies were excluded from the review if they made comparisons other than those pre-specified or if data were unavailable. Excluded studies are listed with reasons for their exclusion.
D E S C R I P T I O N O F S T U D I E S
For the current update (2007) As the populations and the type and timing of interventions varied so greatly among the studies, the decision was made by the authors to separate studies of UI prevention (pre-operative recruitment of all men undergoing surgery which included a pre-operative intervention plus or minus post-operative intervention) ( 
Types of outcome measures
There was lack of consistency in the reporting of outcome measures. Porru 2001; van Kampen 1998) . (Porru 2001) reported using the American Urological Association symptom score and a five point grading scale to assess strength of pelvic floor muscle contraction by digital evaluation. Definitions of UI, on which the number of patients remaining incontinent at the end of the trial was based, varied from the use of pads to a specified amount of urine lost. Many authors did not specify a definition of UI for their trial.
Secondary outcomes for this review pertaining to quality of life issues were included in some trials, but the findings were often provided as a narrative summary rather than numerically, and so were not available in a form suitable for statistical analysis. None reported on economic issues. Thus, none of the secondary outcomes identified for this review were included in the analysis. Five trials reported measures of quality of life or satisfaction, but they were all different measures and not reported in a format that allowed them to be included in analysis. Moore used two validated quality of life measures (Moore 1999). Although there was a moderate correlation between one measure and the amount of urine lost, there were no differences between intervention and control groups. Satisfaction with the treatment was reported as high, based on face to face interview. of which were open-ended allowing for written comments from participants. The intervention group was found to have a significantly higher satisfaction rate.
M E T H O D O L O G I C A L Q U A L I T Y
The quality assessment criteria of the Cochrane Incontinence Group assume that the avoidance of bias is best achieved by: a randomised trial with secure concealment of allocation prior to formal entry; adequate blinding of patients, outcome assessors and health care providers; description of reasons and numbers of withdrawals and dropouts; and analysis on an intention to treat basis. None of the early trials fulfilled all these criteria. However recent trials have fared much better in terms of secure concealment of allocation and blinding.
Overall, the quality of trials included in the review was low to moderate. Although all 17 studies were identified as randomised controlled trials, only six ( 
Differences between trials
There was clinical heterogeneity regarding UI status at baseline, timing of recruitment and intervention, content of intervention and control treatments. The wide range of continence definitions from pad free to less than 1 gram of urine loss on pad test and high dropout rates also mean that the groups of people studied differed. Because of this heterogeneity, it was decided that data from the trials should not be used to derive summary estimates, and this should be borne in mind when interpreting the data. When the trials were considered individually, there were statistically significant differences following the intervention only in one trial (van Kampen 1998). 
Number not cured
Post-operative interventions using electric or magnetic energy (e.g. post-operative anal electrical stimulation, perineal electrical stimulation, transcutaneous electrical nerve stimulation (TENS), extracorporeal magnetic innervation (ExMI)) versus no treatment or sham treatment (Comparison 02)
Only a single trial with data was identified for this comparison (Moore 1999). This trial reported using PFMT with anal electrical stimulation. This was the second intervention group in the Moore trial.
One study of extracorporeal magnetic innervation versus no therapy or sham therapy (Nehra 2001) previously listed as ongoing was excluded as attempts to contact the authors for data were not successful.
Number not cured
There was no statistically significant difference between the groups in terms of reported UI symptoms (Comparison 02.01), but with wide CIs (RR 0.87; 95% CI 0.53 to 1.42).
Pad test
The data favoured the control group at 3 to 6 months, but there was no statistically significant difference between the groups on grams of urine lost (pad test) at any of the other time points (Comparison 02.02). SDs were large, indicating skewed distribution of data, and the confidence intervals were wide.
Post-operative lifestyle adjustment versus no treatment or sham treatment (Comparison 03)
No trials were identified.
Post-operative combinations of treatments versus no treatment or sham treatment (Comparison 04)
One trial reported using PFMT with anal electrical stimulation as well as biofeedback (Opsomer 1994) . Incontinent men (loss of more than 1 gram of urine on pad test) at six weeks after RP were randomised to intervention and control groups. The intervention group had two sessions of biofeedback and electrical stimulation (type unspecified) in addition to continuing the PFMT taught to both groups. The data were few with cure rates based on only four men having UI at 3 to 6 months (Comparison 11.01). Pad test results were not reported in a form that could be used and attempts to contact the author were unsuccessful.
Post-operative use of one treatment versus another active treatment (Comparison 05)
Three trials comparing one active treatment to another were identified (Floratos 2002; Hoffman 2005; Moore 1999 ).
• Floratos 2002 randomised 28 men with post RP UI to PFMT and 14 to verbal feedback.
• Two trials (Hoffman 2005; Moore 1999) compared post-operative PFMT plus anal electrical stimulation with PFMT alone in men incontinent after RP. One trial (Moore 1999) reported two arms with a total of 37 men.
• Another arm of the (Hoffman 2005) study examined post-operative RP PFMT plus perineal electrical stimulation versus PFMT alone
One trial compared use of machine-led biofeedback to augment PFMT versus exercises taught using the standard method of verbal feedback from digital anal assessment (Joseph 2000) . The verbal feedback group was treated as "control" or "PFMT alone" for the analysis. The trial was very small (a total of only 11 men) and reported as a pilot. One man had UI after TURP, the remainder after RP. Patients who were incontinent at least six months after surgery were randomised to either the biofeedback or verbal feedback groups. The results were not published, but the author supplied raw data on the pad test results so that means and standard deviations could be calculated by the review authors. Two men (of four still followed up) in the biofeedback group had urine loss on the pad test compared to none of three in the verbal group after three months. There are many potentially confounding variables in this trial, acknowledged by the author. Also, as all the men were incontinent for some time after surgery, they may represent a group with persistent UI.
One study of PFMT plus transcutaneous electrical nerve stimulation versus PFMT alone (Ceresoli 2002) previously listed as ongoing was excluded attempts to contact the author for data were not successful.
Number not cured Again, definition of cure varied with each study: <1 gm urine loss on 1 hour pad test to <8 gm on 24 hour pad test. There was no difference in UI rates in the Moore 1999 trial, but confidence intervals were wide (Comparison 05.01).
Pad tests
Using a 20 minute provocative pad test, (Wille 2003) reported results favoured PFMT with anal ES at both 3 to 6 and 6 to12 months, but the 3 to 6 month MD was not significant and confidence intervals were wide. At 6 to 12 months the difference between groups was statistically significant with narrower confidence intervals (MD -3.31, 95% CI -0.67 to -0. • Two trials (Bales 2000; Burgio 2005) compared pre-operative PFMT plus biofeedback with a no-treatment or placebo-treatment control group for all men before RP.
• One trial (Filocamo 2005) compared postoperative PFMT plus digital anal biofeedback with a no-treatment or placebo-treatment control group for all men after RP.
• One small trial (Parekh 2003) attempted an intervention of both pre and post-operative PFMT plus biofeedback (digital or anal-probe) compared to no intervention in men undergoing RP.
• Another trial (Mathewson-Chapman 97) provided pre-operative education and baseline perineal muscle evaluation to both treatment and control groups, with the treatment groups also receiving PFMT with biofeedback post-operatively.
In the (Bales 2000) trial, randomisation occurred preoperatively and initial instruction on PFMT and biofeedback training (surface electrodes) for the intervention group was provided two to four weeks prior to RP. The control group received only postoperative verbal instruction on PFMT, and both groups were encouraged to practice PFMT four times daily once the catheter was removed at two weeks after surgery. (Burgio 2005) randomised men to a single pre-operative session of biofeedback assisted PFMT and daily PFMT, or to a control group of usual care with simple instructions to interrupt the stream when voiding. In the (Filocamo 2005) trial, men received three formal PFMT instruction sessions from a therapist after operation. In the (Parekh 2003) trial, participants randomised to the intervention group were given two physical therapist led treatment sessions, which included PFMT and digital or anal-probe biofeedback, prior to surgery and every three weeks for 3 months post-operatively, as well as home exercises. 
Number not cured
Post-operative lifestyle adjustment versus no treatment or sham treatment (Comparison 13)
Post-operative combinations of treatments versus no treatment or sham treatment (Comparison 14)
Post-operative use of one treatment versus another active treatment (Comparison 15)
No trials were identified. 
TURP
Pad tests (number not cured)
There were no significant differences between the groups in the rates of men incontinent at less than three months, but the confidence intervals were wide (Comparison 16.01). 
Pre
Pre with or without post-operative lifestyle adjustment versus no treatment or sham treatment (Comparison 18)
Pre with or without post-operative combinations of treatments versus no treatment or sham treatment (Comparison 19)
Pre with or without post-operative use of one treatment versus another active treatment (Comparison 20)
Containment of UI (all men with residual UI)
External penile compression devices (penile clamps) versus no treatment or sham treatment (Comparison 21)
One trial compared three different penile compression devices (Cunningham clamp, U-Tex Male Adjustable Tension Band and C3 penile compression device) with a control period of no device (Moore 2004). A randomised block assignment was used with a multiple period crossover design, so that each of the 12 participants had a control period of no device and three periods in which the different devices were used. All external compression devices reduced the weight of urine lost on a four-hour pad test compared to the control period (P less than 0.05, Other Data Table 18 .02), but none completely eliminated urine loss. Satisfaction was based on ease of application, comfort and efficacy. The device preferred by the largest number of men was also that with the lowest urine loss (the Cunningham clamp) (Other Data Table 21 ).
However, this was also the device with the greatest reduction in systolic blood flow velocity (P less than 0.05 versus control period, Other Data Table 21 .03, 04), raising the possibility of safety issues if applied too tightly. In the trial, men were able to judge when to release the device, and the authors recommended that its use should therefore be limited to men who are cognitively intact, are aware of bladder filling, have normal genital sensation and intact penile skin, and have sufficient manual dexterity to open and close the device (Moore 2004).
Potential for publication bias
Potential for publication bias was examined graphically using a funnel plot. Using the dichotomous data from the same 12 trials included in the comparison for the sensitivity analysis, a funnel plot (relative risk, fixed effects) was generated in MetaView. Considerable funnel plot asymmetry was present, with the smaller trials favouring treatment missing from the left of the funnel, but those favouring control present. Since small studies usually tend to overestimate rather than underestimate the effect of an intervention (Sterne 2001), attributing the asymmetry to publication bias remains counterintuitive. Again, the more plausible explanation of funnel asymmetry lies in the poor quality of the studies or in true heterogeneity (variations in treatment type or intensity or risk differences attributable to studies of different sizes) (Higgins 2005). As there were only sixteen trials included in this review, no statistical analysis to examine publication bias was undertaken. In meta-analyses of less than 20 trials, sensitivity of these methods (rank correlation or linear regression) is considered low (Sterne 2001).
D I S C U S S I O N
This review incorporates a broad array of possible interventions under the umbrella term of conservative management of postprostatectomy UI. The populations studied included men undergoing prostatectomy for both benign and malignant disease. As well, the interventions occurred preoperatively, post operatively or both. Some early studies (e.g. Moore 1999; Joseph 2000) included men who had been incontinent for some time (up to months) after surgery. More recent studies have focused on the preoperative or post operative period immediately after catheter removal. Seventeen trials met the inclusion criteria, 15 trials amongst men after RP, one trial after TURP and one after either operation. There was considerable variation in the interventions, populations and outcome measures. Given this clinical heterogeneity it was decided to differentiate the studies, and the comparisons, by pre operative, post operative or combined intervention time periods and by type of surgery (TURP or RP) in this version of the review.
The majority of trials in this area continue to be of modest quality. Data were not available in all the trials for many of the prestated outcomes. Confidence intervals have tended to be wide except for the more recent studies, and it continues to be difficult to reliably identify or rule out a useful effect. Few trials used the primary outcomes of interest, patient reported symptoms and the standardized pad test. Most used a variety of subjective outcomes derived from patient reported symptoms to define continence. There were no trials which examined lifestyle adjustments in alleviating UI after prostatectomy.
There may be some enhancement of quality of life in men after prostatectomy through the support provided by attending a clinic offering these interventions (Moore 1999). (Hoffman 2005) also measured quality of life, and did not find a difference in this outcome between the 3 groups studied in rehabilitation programs, reporting that all groups improved on continence and quality of life, but that quality of life improvement was mostly achieved during the inpatient rehabilitation period which might also suggest some effect of being in a program. (Burgio 2005) also included a quality of life measure.
It is acknowledged that UI after prostatectomy will resolve over time in most men. There was some evidence from two trials that use of PFMT (compared to no treatment) may help to resolve this more quickly, based on the results from one trial amongst incontinent men (van Kampen 1998) 2004). This may be a viable alternative for some cognitively capable men providing they take into account safety issues such as adequate sensation and ability to remove the device when it feels too tight or the bladder is full. Men in one trial reported a preference for one type of external compression device compared to two others or no treatment. The effect of other conservative interventions such as lifestyle changes remains undetermined as no trials involving these interventions were identified.
Conservative interventions tend to be resource-intensive strategies that require people, equipment and clinic space, so administrators will look for evidence of efficacy. Funding has been an issue given the inconclusive nature of the evidence to date. For example, in the United States, the centres for both Medicare and Medicaid Services were considering whether to withdraw funding for biofeedback and pelvic floor electrical stimulation in the treatment of UI of any etiology based on a lack of evidence regarding effectiveness. Through a lobbying effort from service providers and manufacturers, these modalities continued to be covered in the United States (Thompson 2002) . However, as controversy about funding is likely to continue, there is a need for continued research in the area to determine which groups of patients are most likely to benefit from conservative interventions.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
In keeping with conclusions from earlier versions of this review, at this point there remains no clear support that conservative management of any type for postprostatectomy UI is either helpful or harmful, whether delivered as treatment to men who are incontinent or as prevention to all men undergoing surgery.
No trials have tested the effect of lifestyle changes alone. Longterm UI may be managed by external penile clamp, but there are safety problems.
Implications for research
UI after prostatectomy is a distressing problem and, although conclusive evidence does not exist, conservative approaches form part of current management. Well-designed clinical trials are needed to clarify the role of these therapies.
As there are known differences in the cause and prevalence of UI between men after TURP and after RP, these groups of men should continue to be studied separately. Prevention trials in all men having surgery should be evaluated separately from treatment trials of men with urinary incontinence after surgery.
Most of the trials included in this review used very different protocols of intervention type, timing and intensity. In order to determine the effects of specific protocols and modalities, large adequately powered trials using common protocols are needed. Replication studies using similar protocols in different populations would also assist in identifying the populations in which specific conservative management approaches are likely to be most effective.
Definitions and measurement of outcomes varied in the included trials. Future trials must attempt to use broadly accepted definitions, such as those of the International Continence Society and to make use of objective measures such as the pad test or urinary diaries in determining if continence has been achieved. Researchers must also focus on either the 1 hour or 24 hour pad test, as the results of these two measurements are not equivalent.
Lastly, authors should be encouraged to ensure appropriate randomisation and blinding of trials and to report these adequately, using the guidelines of the CONSORT statement. 
P O T E N T I A L C O N F L I C T O F I N T E R E S T
One of the reviewers (KNM) was an investigator in three of the seventeen included trials. Another (CMAG) is the Chief Investigator of an ongoing study (Glazener 2004).
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References to studies included in this review
Control N=50 Interventions
Pre-operative intervention.
Intervention: 2-4 weeks prior to surgery, participants underwent a 45 minute session with nurse trained in biofeedback. Patients were instructed to perform graded PFMT. Contractions of 5-10 seconds, 10-15 repetitions were performed with biofeedback (surface electrodes used to measure muscle strength). Advised to practice the exercises 4 times per day until surgery.
Control: No biofeedback training. Written and brief verbal instructions from a nurse on how to perform PFMT (isolate muscle that stops urine flow, practice 4 times per day, 10-15 repetitions).
Both: Encouraged to perform PME 4x per day after catheter removal 2 weeks post op.
Length of follow-up: 6 months Continence definition: use of 1 pad or less per day
Data collection: at 1, 2, 3, 4, and 6 months postoperatively.
Notes
There was no significant difference in incontinence between the groups.
Allocation concealment B -Unclear
Study Burgio 2005
Methods Randomised: yes Method of allocation: stratified by age and tumor differentiation, then randomised using computer generated random numbers, block size of 4 to ensure equity of number in each group. Blinding: Intervention providers and bladder diary scorers were blinded. Dropouts: 6 participants in the intervention group, and 7 in the control were excluded after randomisation as surgery was cancelled. At 6 months, 6 in the intervention and 4 in the control were lost to follow-up.
Participants
Recruitment: pre-operative Included: all men undergoing RP N=125 volunteer patients randomised, 13 excluded after randomisation. Analysis on N=112 men aged 53-68 who underwent radical prostatectomy for prostate cancer. To be eligible, the men had to be ambulatory, continent and identied at least 1 week prior to their surgery. Intervention N=57 Control N=55 Interventions Pre-operative intervention.
Intervention: Single session of biofeedback (rectal probe to measure intra-abdominal rectal pressure and external anal sphincter contraction) assisted behavioural training. Feedback and verbal instruction used to teach control of pelvic muscles. Taught to contract sphincter during 2-10 seconds periods separated by 2-10 seconds of relaxation, dependent on ability. Written instructions for daily at home practice of 45 PFM exercises daily (3 sessions of 15 exercises each time). Additionally instructed to slow or interrupt voiding once daily. Encouraged to exercise daily preoperatively, then resume when catheter removed post-operatively.
Control: usual care of brief verbal instructions post operatively to interrupt the voiding stream plus any instruction from physician.
Length of follow-up: 6 months Outcomes Main outcome:
Continual and/or episodic urine loss using bladder diaries, incontinent pads or other products Secondary outcomes: Impact of incontinence and quality of life pre-operatively and at follow-up contacts by IIQ, SCL-90-R and SF-36.
Continence definition: 3 consecutive weekly 1 day diaries showing no leakage or a 7 day diary showing no leakage.
Data collection: One day bladder diaries mailed in each week. Questionaire on bladder control, lifestyle and 7 day bladder diary at 6 weeks, 3 months and 6 months post surgery.
Notes
Time to continence was significantly reduced in the intervention group. The intervention group had a significantly smaller proportion of those with severe or continual leakage at 6 months, and stress type urine loss. No differences on quality of life, return to work or activities between the groups. Analysis by "intention to treat". Additional data supplied to KFH by author.
Allocation concealment A -Adequate
Study Dubbelman 2004
Methods Randomised: yes Method of allocation: not described. Blinding: not mentioned. Dropouts: 5 were excluded after consent (3 had positive nodes, 2 were not incontinent). Of the 70 men incontinent one week after catheter removal who were randomised to two groups, 7 dropped out due to bladder neck contracture (4), withdrawal of consent (2) or lack of understanding (1). Control: Instruction with verbal feedback and an information pamphlet with instructions to perform PME 50-100 times daily at home.
Length of follow-up: 6 months Outcomes Main outcome: incontinence episodes measured by 1 hour pad test and continence questionaire (pads used, number of incontinence episodes)
Continence definition: Incontinence defined as a urine loss of > 1 gm on the 1 hour pad test. 2 or more pads/day a not deemed a "socially acceptable continence rate"
Data collection: baseline, 1, 2, 3 and 6 months.
Notes
Level of incontinence in both groups declined over the 6 months of the study. Control group had less urine loss and appeared to regain continence sooner, but the difference was not significant. Additional data supplied to KFH by author. Intervention: Biofeedback (perineal patch EMG) enhanced PFMT; exercise treatment sessions at 6, 7, 9, 11, and 16 weeks postoperatively.
Allocation concealment B -Unclear
Control: completed bladder diary but did not have any other intervention.
Length of follow-up: 12 months.
Outcomes
Main outcome: urine loss measured by voiding diary, 48 hour pad test (reported as mean grams of urine lost in 24 hours), and incontinence questionnaire.
Continence definition: Not clear. Participants described as "completely dry" or with "significant incontinence".
Data collection: 6, 12 and 24 weeks Notes There were no significant differences between treatment or control groups on any of the outcome measures at any of the measurement intervals.
Allocation concealment B -Unclear
Study Hoffman 2005
Methods Randomised: yes Method of allocation: computerized randomization. Blinding: unclear Dropouts: 1 participant from each intervention group had dropped out by discharge; 15 dropouts from the perineal group, 31 from the anal group and 5 from the control group dropped out by 3 months. Intention to treat: no Participants Recruitment: post-operative Included: men incontinent post RP in an inpatient rehabilitation program N= 180 men (prior to drop-outs) Randomly assigned to 3 groups (sixty in each group).
Interventions Post-operative intervention. Intervention: (group 1): perineal E Stim plus physiotherapy (PFMT).
Intervention (group 2): anal E Stim plus physiotherapy (PFMT).
Control: PFMT alone. 
Notes
No differences between the groups. Improvement seen in all patients at 12 months. Data not published in article. Raw data supplied to reviewer (KFH) who calculated means and standard deviations. These were reviewed by a second reviewer (KNM). Intervention: Pre-operatively received further instruction and practice with PME protocol Home exercises and biofeedback (anal probe) (Incare 8900); practiced at home 3 times a week, starting with daily 15 PFMT and increasing by 10 every 4 weeks to a maximum of 35 PFMT.
Allocation concealment B -Unclear
Study
Mathewson-Chapman 97
Control: Post-operatively no further interventions until week 5 when pelvic muscle strength was assessed.
Both: Pre-operatively, both groups received 30 mintues prostate education programme and baseline 'perineal muscle evaluation' (not defined); as well all were taught to contract the perineal muscle and hold for a few seconds prior to standing, lifting or coughing and limit the amount of tea, chocolate, alcohol and over-thecounter medications.
Length of follow-up: 12 weeks.
Outcomes
Main outcome: urine loss measured by 24 hour pad test, frequency of micturitions (self-recorded bladder diary), number of pads used; days to achieve continence from baseline.
Secondary outcomes: Perineal muscle strength (method not described)
Continence definition: self report of return of continence Data collection: Three day bladder diaries at weeks 2, 5, 9 and 12. 24hour pad test at weeks 5 and 12.
Notes Inclusion of other modalities such as caffeine limitation and using perineal muscles during any event which increased abdominal stress may have masked any treatment benefit. Interventions Post-operative intervention.
Allocation concealment B -Unclear
Study
Intervention: M aximum 24 weekly, 30-minute treatment protocol and home exercise protocol of 2-3 times a day
Control: verbal and written information on PFME and weekly telephone contact by a urology nurse.
Both: At 4 weeks post surgery, both groups received standardized verbal and written instruction about PFMT and recovery after radical prostatectomy by one dedicated physiotherapist or registered nurse at each site Length of follow-up: 12 months Outcomes Main outcome: grams of urine loss on 24 hour pad test Secondary outcome: IPSS, IIQ-7 (Incontinence Impact Questionnaire), voiding diary, and subjective continence.
Continence definition: object was <8 gm of urine loss on 24 hour pad test; subjective continence defined as yes/no.
Data collection:
All measures obtained at baseline (preoperatively) and at 4, 8, 12, 28 weeks and 1 year post operatively.
Notes
At 8 weeks 21 (23%) control; 21 (20%) treatment were dry; at 12 weeks, 24 (28%) and 32 (32%); at 16 weeks, 33 (40%) and 42 (44%); at 28 weeks, 39 (50%) and 45 (47%); and at 12 months 73% of control and 67% of treatment groups were dry (<8 gm on pad test). No significant differences between groups on this or on symptom and quality of life measures or diary at any time point post operatively. The majority of subjects reported a low impact of incontinence as per the IIQ-7 and fewer LUTS at 12 months than at baseline as per the IPSS. The majority were very satisfied with treatment.
Allocation concealment A -Adequate
Study Opsomer 1994
Methods Randomised: yes Method of allocation: method not described Blinding: none Drop outs: 4 Intention to treat: unclear. Participants Recruitment: post-operative Included: men incontinent post RP 6 weeks after six week after surgery.
N-=43 (39 completed study) Intervention N=21 Control N=22 Interventions Post-operative intervention.
Intervention: PFMT plus biofeedback plus electrical stimulation directed by physiotherapist.
Control: PFME on their own without medical supervision.
Length of follow-up: 12 weeks. Intervention: 2 treatment sessions preoperatively. Session 1 consisted of PFMT in a hook lying position. Session 2 was on an exercise ball. Teaching methods varied and included verbal cues, visualization with an anatomical model, palpation or biofeedback with rectal probe. Post-operatively, PFMT was reviewed and participants were seen every 3 weeks for 3 months by a physiotherapist. Home exercise for 6 months or more for those requiring further physical therapy guidance.
Outcomes
Control: No formal education on PFMT pre-operatively, telephone or face to face follow-up at least monthly.
Length of follow-up: 12 months Outcomes Main outcome: urine loss measured by number of pads used daily.
Continence definition: 0 pads or 1 precautionary pad used Data collection: UI questionnaires at 6, 12, 16, 20, 28, and 52 weeks Notes Greater number of the intervention group gained continence earlier than the control group at 3 months (only point of statistical difference). Minimal long term effect as continence rates the same at 1 year.
Allocation concealment B -Unclear
Study Porru 2001
Methods Randomised: yes Method of allocation: Not described. Blinding: Report stated that urologist performing digital evaluation of pelvic floor muscle contraction was blinded to the study group. Dropouts: Intervention -2, control -1. 
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